This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Agilon Health CEO Resigns, Guidance Withdrawn
Business CEO resignation

Agilon Health CEO Resigns, Guidance Withdrawn

Analysis based on 7 articles · First reported Feb 05, 2026 · Last updated Feb 17, 2026

Sentiment
-60
Attention
4
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The market reacted negatively to Agilon Health's announcement, with its shares plummeting over 27% in after-hours trading. This event signals a significant loss of investor confidence in Agilon Health and could lead to increased scrutiny from legal firms like DJS Law Group.

Healthcare Legal
Event Summary

Agilon Health announced on August 4, 2025, that its President, CEO, and Board Director, Steven Sell, resigned from his positions. Concurrently, the company released its second-quarter 2025 earnings and withdrew its previous full-year 2025 earnings guidance. This news caused Agilon Health's shares to fall by more than 27% in after-hours trading. DJS Law Group has initiated an investigation into whether Agilon Health issued misleading statements or failed to disclose pertinent information to investors, inviting affected shareholders to participate.

Key Actions
95 Agilon Health withdrew full year 2025 earnings guidance
90 Steven Sell stepped down from leadership positions Agilon Health
90 Agilon Health shares fell more than 27% in after-hours trading
70 DJS Law Group initiated investigation into misleading statements Agilon Health
Entities Involved
stock
Agilon Health
Agilon Health announced the resignation of its President, CEO, and Board Director Steven Sell, and simultaneously withdrew its full-year 2025 earnings guidance. This news led to a more than 27% drop in its share price during after-hours trading, indicating a significant negative impact on the company's market valuation and investor confidence.
Importance 100 Sentiment -80
per
Steven Sell
Steven Sell stepped down from his positions as President, CEO, and Board Director of Agilon Health. This departure, coupled with the withdrawal of earnings guidance, suggests a challenging period for his leadership and the company's immediate future.
Importance 80 Sentiment -50
priv
DJS Law Group
DJS Law Group is initiating an investigation into Agilon Health regarding potentially misleading statements and/or undisclosed information. This action positions DJS Law Group as a potential advocate for shareholders who suffered losses, aiming to enhance investor return through legal action.
Importance 30 Sentiment 20
Relationships
Steven Sell related ↔ Agilon Health
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.